SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers is trending following its decision to pull a newly launched compounded weight-loss pill due to regulatory pressure and legal threats. This move has sparked debate, with some viewing it as a significant setback while others believe it strategically removes a legal overhang and positions the core telehealth platform for a rebound, amplified by its Super Bowl ad.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DraftKings is trending due to record Super Bowl betting volume and its ongoing expansion into prediction markets, sparking community debate over immediate revenue opportunities versus competitive pressures and the evolving regulatory landscape surrounding these platforms.

JERRY (JYAI) is a Matt Furie's artistic style; it features an AI-powered content creation hub that produces community-driven video series and art.  Jerry the Turtle, created by Matt Furie, is a character inspired by Furie’s artistic style. JERRY is also an AI-driven meme coin with an ambitious vision. The goal is to establish an AI-powered production house dedicated to creating a video series or episodes featuring characters from Matt Furie’s universe alongside those from Jerry’s world.  This unique blend of characters aims to produce the ultimate crypto-based series. Additionally, we are developing an app that will offer an exclusive, ad-free video series featuring characters from both Matt Furie’s creations and the Jerry Universe. Users will be able to download and share videos directly through the platform.  But that’s not all! A special Jerry Art Panel will showcase original Jerry characters, artwork, and fan creations—free to explore, download, and share with the community.

Jerry The Turtle By Matt Furie

JYAI CRYPTO is trending as community anticipation builds around its confirmed Tier 1 exchange listings and recent debut on platforms like KuCoin Alpha and Bitget. Enthusiasts are actively comparing it to early successful memecoins, fueled by its aggressive 12-week marketing initiative and developer updates.

UNI is the governance token for Uniswap, an Automated Market Marker DEX on the Ethereum blockchain. The UNI token allows token holders to participate in the governance of the protocol. Key decisions such as usage of the treasury or future upgrades can be decided through a governance vote.

UniSwap

Uniswap (UNI) is trending as its community overwhelmingly supports a game-changing governance proposal to activate a fee switch and implement a significant token burn, aiming to align the protocol's high fee generation with UNI's value and establish deflationary tokenomics.

Cleveland-Cliffs, Inc. is a flat-rolled steel company, which engages in provision of iron ore pellets to the North American steel industry. It focuses on the production of metallic and coke, iron making, steelmaking, rolling and finishing, and downstream tubular components, stamping, and tooling. The company was founded in 1847 and is headquartered in Cleveland, OH.

Cleveland-Cliffs Inc

Cleveland-Cliffs is trending as investors debate the impact of a recent equity offering, with community focus on a potential partnership with POSCO and upcoming earnings. Sentiment remains split between those optimistic about rising steel prices and domestic demand, and others concerned about management's strategy for long-term shareholder value.

Pagaya Technologies Ltd. engages in the development of AI and data networks for the financial industry. Its product deploys data science, machine learning and AI technology to evaluate the customers' applications in real time. The company was founded by Gal Krubiner, Sanjiv Das, Yahav Yulzari, and Avital Pardo on March 20, 2016 and is headquartered in New York, NY.

Pagaya Technologies Ltd - Ordinary Shares - Class A

Pagaya Technologies Ltd

Pagaya Technologies is actively trending ahead of its Q4 earnings report on February 9, with community speculation about a potential leak and high expectations for a strong beat and optimistic 2026 guidance, driven by its AI-powered credit platform and recent substantial ABS and forward flow agreements. Despite these strong fundamentals and expanding partnerships, the stock remains a hotly debated topic, with many viewing it as significantly undervalued while others express frustration over persistent market volatility and broader fintech sector pressures.

Pinterest, Inc. engages in the operation of a pinboard-style photo-sharing website. It allows users to create and manage theme-based image collections such as events, interests, and hobbies. The company was founded by Benjamin Silbermann, Paul C. Sciarra, and Evan Sharp in October 2008 and is headquartered in San Francisco, CA.

Pinterest Inc - Ordinary Shares - Class A

Pinterest Inc

Pinterest is trending amid a strategic workforce reduction focusing on AI initiatives, fueling community discussion around its perceived undervaluation and strong balance sheet, especially as rumors circulate about potential acquisition interest from major players like OpenAI and Reddit ahead of its highly anticipated earnings report.

Binance Coin is the cryptocurrency of the Binance platform. It is a trading platform exclusively for cryptocurrencies. The name "Binance" is a combination of binary and finance.  Thus, the startup name shows that only cryptocurrencies can be traded against each other. It is not possible to trade crypto currencies against Fiat. The platform achieved an enormous success within a very short time and is focused on worldwide market with Malta headquarters. The cryptocurrency currently has a daily trading volume of 1.5 billion - 2 billion US dollars and is still increasing.  In total, there will only be 200 million BNBs. Binance uses the ERC20 token standard from Ethereum and has distributed it as follow: 50% sold on ICO, 40% to the team and 10% to Angel investors. The coin can be used to pay fees on Binance. These include trading fees, transaction fees, listing fees and others. Binance gives you a huge discount when fees are paid in BNB.   The schedule of BNB fees discount is as follow: In the first year, 50% discount on all fees, second year 25% discount, third year 12.5% discount, fourth year 6.75 % discount, and from the fifth year onwards there is no discount. This structure is used to incentivize users to buy BNB and do trades within Binance.  Binance announced in a buyback plan that it would buy back up to 100 million BNB in Q1 2018. The coins are then burned. This means that they are devaluated to increase the value of the remaining coins. This benefits investors. In the future, the cryptocurrency will remain an asset on the trading platform and will be used as gas.  Other tokens that are issued by exchanges include Bibox Token, OKB, Huobi Token, and more.

Binance

BNB is trending amid intense community debate concerning alleged market manipulation by the exchange and a recent settlement for misleading investors. Despite these controversies, proponents highlight significant ecosystem expansion, including new licenses, user growth, and major financial product integrations.

Tidal Trust II - YieldMax Gold Miners Option Income Strategy ETF

YieldMax Gold Miners Option Income Strategy ETF

A record-high dividend payout is fueling strong interest in GDXY, a gold miners options income ETF, as gold prices climb to new all-time highs. The community is actively discussing its appeal as a high-yield, gold-backed hedge, particularly with an upcoming shift to weekly distributions.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is garnering significant buzz following its impactful Super Bowl commercial featuring Christina Applegate, which the community expects to drive Briumvi's patient adoption and sales amidst positive preliminary financial results and ongoing discussions about its strong market position and buyout potential.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Sanofi Invests $18.96 Million in Immuneering Corporation $IMRX

Sanofi bought a new stake in shares of Immuneering Corporation (NASDAQ:IMRX - Free Report) in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The...

Immuneering Corporation (NASDAQ:IMRX) Given Consensus Recommendation of "Moderate Buy" by Brokerages

Immuneering Corporation (NASDAQ:IMRX - Get Free Report) has earned an average recommendation of "Moderate Buy" from the seven research firms that are currently covering the firm, Marketbeat reports...

Immuneering (NASDAQ:IMRX) Insider Purchases $24,990.00 in Stock

Immuneering Corporation (NASDAQ:IMRX - Get Free Report) insider Harold Eugene Brakewood purchased 5,250 shares of the business's stock in a transaction dated Friday, January 16th. The shares were...

Immuneering (NASDAQ:IMRX) Insider Harold Eugene Brakewood Purchases 5,250 Shares of Stock

Immuneering Corporation (NASDAQ:IMRX - Get Free Report) insider Harold Eugene Brakewood purchased 5,250 shares of Immuneering stock in a transaction dated Friday, January 16th. The shares were...

Thomas Schall Purchases 21,645 Shares of Immuneering (NASDAQ:IMRX) Stock

Immuneering Corporation (NASDAQ:IMRX - Get Free Report) Director Thomas Schall bought 21,645 shares of the business's stock in a transaction that occurred on Thursday, January 15th. The shares were...

Immuneering Corporation (NASDAQ:IMRX) Sees Significant Growth in Short Interest

Immuneering Corporation (NASDAQ:IMRX - Get Free Report) saw a large growth in short interest in December. As of December 31st, there was short interest totaling 10,924,303 shares, a growth of 43.1...

Immuneering (NASDAQ:IMRX) Insider Acquires $10,501.86 in Stock

Immuneering Corporation (NASDAQ:IMRX - Get Free Report) insider Brett Matthew Hall acquired 2,298 shares of the stock in a transaction that occurred on Thursday, January 15th. The shares were bought...

Insider Buying: Immuneering (NASDAQ:IMRX) Insider Purchases 2,298 Shares of Stock

Immuneering Corporation (NASDAQ:IMRX - Get Free Report) insider Brett Matthew Hall purchased 2,298 shares of the stock in a transaction that occurred on Thursday, January 15th. The stock was...

Immuneering (NASDAQ:IMRX) Insider Purchases $10,897.90 in Stock

Immuneering Corporation (NASDAQ:IMRX - Get Free Report) insider Leah Neufeld bought 2,626 shares of Immuneering stock in a transaction on Tuesday, January 13th. The shares were acquired at an average...

Immuneering (NASDAQ:IMRX) Insider Acquires $10,897.90 in Stock

Immuneering Corporation (NASDAQ:IMRX - Get Free Report) insider Leah Neufeld bought 2,626 shares of Immuneering stock in a transaction dated Tuesday, January 13th. The shares were acquired at an...

Immuneering Corp. operates as a clinical-stage oncology company, which engages in developing medicines for cancer patients. Its pipeline of drug candidates focuses on treating aspects of disease that have eluded conventional approaches, including cancer cachexia and metastasis. The company was founded by Robert J. Carpenter and Benjamin J. Zeskind in 2008 and is headquartered in Cambridge, MA.

Immuneering Corp - Ordinary Shares Class A

Up 5%

Down 5%

Markets are hovering near key levels, making the next 5% move especially important for sentiment. A breakout higher could reinforce the bull case, while a 5% drop may signal rising risk and tighter conditions. Which comes first?

IMRX
Immuneering Corp

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest IMRX News

IMRXImmuneering Corp